TORONTO, April 13, 2021 / CNW / – This year marks the 100th anniversary of insulin discovery. The Ontario Pharmacists Association (OPA) is proud to announce a partnership with BD Canada and Ascensia Diabetes Care to celebrate the landmark anniversary and highlight the critical involvement of pharmacy professionals in the treatment of the disease. The revolutionary Canadian discovery of Sir Frederick Banting and his assistant Charles Best is a leading medical advancement that has fundamentally changed the lives of millions of people around the world.
Celebrating 100 Years of Insulin Discovery – Ontario Pharmacists Association, BD Canada, Ascensia Diabetes Care (CNW Group / Ontario Pharmacists Association)
To commemorate the Nobel Prize-winning discovery of insulin OPA, BD Canada and Ascensia are jointly offering a variety of online events and programs, including live webinars, competitions and educational workshops from April 2021, until June 2021. The events and programs will celebrate the milestone and focus on providing pharmacy professionals with world-class guidance and resources so they can continue to provide adequate support to patients with diabetes. As accessible healthcare providers, pharmacy professionals are integral members of a diabetes care team that supports patients with insulin delivery and the best possible treatment for the disease.
“At BD, we are thrilled to sponsor OPA as we commemorate the 100th anniversary of the discovery of insulin. BD is proud to have supported our pharmacists and people with diabetes since 1924 when we introduced the first insulin injection made, “he said Jennifer Spearen VP of Diabetes Care, BD. “We are constantly looking to work with our pharmacy professionals to achieve our shared goals of developing and managing diabetes care for all people with diabetes as BD continues its mission to advance the world of health.”
Over 11 million Canadians live with diabetes or prediabetes. Insulin greatly improves the health outcomes of those with diabetes, but there is an ongoing battle against the disease. Pharmacy professionals in a variety of settings from community pharmacies to hospitals support patient care through education, practical approaches to therapy compliance, and improved clinical outcomes. The combined efforts of pharmacy professionals, other health care providers, and diabetes management therapies reduce the burden on those affected by the disease.
The story goes on
“As a trusted partner in the diabetes community, Ascensia Diabetes Care is proud to celebrate the 100th year of the discovery of insulin in partnership with OPA,” said Ascensia Diabetes Care Annika Pawaroo, Country Head, Ascensia Diabetes Care. “We are excited about this special discovery and look forward to the future. For more than 70 years, our diabetes care team has led the way through continuous research in providing blood glucose monitoring systems that are tailored to the needs of patients. We will continue to proudly work with pharmacy professionals to improve diabetes management and build on the legacy of our longstanding commitment to diabetes. “
As one of Canada OPA is a leading advocacy group for pharmacy professionals and is honored to celebrate 100 years of insulin success with BD Canada and Ascensia Diabetes Care. “OPA is excited to partner with two industry leaders who are committed to improving the health and wellbeing of patients with diabetes,” said OPA Lilliette Davidson, VP Business Management & Development at OPA. “Pharmacy professionals play a key role in achieving optimal health outcomes, and these valuable programs and resources can be applied to their practice in caring for the diabetic patient population.”
The discovery of insulin paved the way for other medical and technological advances that enabled improved support, treatment, and better outcomes for patients with diabetes. As the main point of contact for patients with diabetes, OPA supports pharmacy professionals and offers high quality resources, training and innovative approaches for practice and patient care.
To learn more about the campaign and to subscribe to updates, visit: www.opatoday.com/100YearsOfInsulin.
ABOUT GRANDPA
The Ontario Pharmacists Association is committed to advancing the pharmacy profession and promoting excellence in practice and patient care. With more than 10,000 members, OPA is Canada largest advocacy organization, professional development and drug information provider for pharmacy professionals across Ontario. By harnessing the unique expertise of pharmacy professionals to enable them to reach their full potential and make them more accessible to patients, OPA works to improve the efficiency and effectiveness of the healthcare system. The pharmacy sector plays a strong role in Ontario with an economic impact greater than $ 6.3 billion in 4,600 pharmacies with 60,000 Ontarians. More information about OPA can be found at https://www.opatoday.com.
ABOUT ASCENSIA DIABETES CARE
Founded in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings (formerly Panasonic Healthcare Holdings), Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes. Ascensia already includes the world famous CONTOUR ™ line of blood glucose monitoring systems and aims to add more innovative and life changing products to its portfolio. For more information on Ascensia Diabetes Care, please visit https://www.ascensiadiabetes.ca. © 2021 Ascensia Diabetes Care Canada Inc.
ABOUT BD
BD is one of the largest global medical technology companies in the world, driving the world of health by improving medical discovery, diagnostics, and care delivery. The company supports the heroes at the frontline of the healthcare system by developing innovative technologies, services, and solutions that help advance both clinical therapy for patients and the clinical process for healthcare providers. BD and its 65,000 employees have a passion and dedication to improving the safety and efficiency of the clinician’s treatment process, enabling laboratory scientists to accurately identify disease, and enhancing the skills of researchers to develop the next generation of diagnostics and therapeutics. BD is present in virtually every country and works with organizations around the world to address some of the most challenging global health problems. You can find more information about BD at bd.com/en-ca.
SOURCE Ontario Pharmacists Association
decision
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2021/13/c4238.html
